Coulie Bernard
Insider CIK 1808895 · SQZ Director · PLRX President and CEO, Director · SEPN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SEPN Septerna, Inc. | A Award deriv | 2026-06-26 | 2026-06-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | D To issuer deriv | 2026-04-17 | 2026-04-17 | 146,841 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2026-04-17 | 2026-04-17 | 146,841 | — | $0 | 146,841 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | D To issuer deriv | 2026-04-17 | 2026-04-17 | 327,262 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2026-04-17 | 2026-04-17 | 327,262 | — | $0 | 327,262 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2026-04-17 | 2026-04-17 | 325,000 | — | $0 | 325,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2026-04-17 | 2026-04-17 | 250,000 | — | $0 | 250,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | D To issuer deriv | 2026-04-17 | 2026-04-17 | 440,000 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2026-04-17 | 2026-04-17 | 440,000 | — | $0 | 440,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | D To issuer deriv | 2026-04-17 | 2026-04-17 | 206,300 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2026-04-17 | 2026-04-17 | 206,300 | — | $0 | 206,300 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | D To issuer deriv | 2026-04-17 | 2026-04-17 | 256,300 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2026-04-17 | 2026-04-17 | 256,300 | — | $0 | 256,300 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | D To issuer deriv | 2026-04-17 | 2026-04-17 | 325,000 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | D To issuer deriv | 2026-04-17 | 2026-04-17 | 250,000 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2026-01-22 | 2026-01-26 | 1,230,000 | — | $0 | 1,230,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2026-01-20 | 2026-01-22 | 89,375 | $1.28 | $114.4K | 505,601 | SEC↗ |
| SEPN Septerna, Inc. | A Award deriv | 2025-06-17 | 2025-06-20 | 16,623 | — | $0 | 16,623 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2025-01-23 | 2025-01-27 | 325,000 | — | $0 | 325,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2025-01-23 | 2025-01-27 | 162,500 | — | $0 | 593,017 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2025-01-17 | 2025-01-22 | 52,419 | $11.20 | $587.1K | 430,517 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2024-07-10 | 2024-07-12 | 38,710 | $11.56 | $447.5K | 482,936 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2024-07-09 | 2024-07-11 | 75,625 | — | $0 | 521,646 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2024-01-23 | 2024-01-24 | 256,300 | — | $0 | 256,300 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2024-01-23 | 2024-01-24 | 128,150 | — | $0 | 444,532 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2024-01-17 | 2024-01-19 | 25,721 | $17.23 | $443.2K | 316,382 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-07-17 | 2023-07-19 | 70,150 | $18.01 | $1.26M | 342,103 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2023-07-14 | 2023-07-18 | 137,500 | — | $0 | 412,253 | SEC↗ |
| SQZ SQZ Biotechnologies Co | A Award deriv | 2023-06-14 | 2023-06-15 | 39,875 | — | $0 | 39,875 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-03-30 | 2023-04-03 | 35,339 | $26.52 | $937.2K | 274,753 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2023-03-29 | 2023-03-31 | 68,749 | — | $0 | 310,092 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2023-02-03 | 2023-02-06 | 15,000 | — | $0 | 327,262 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-02-03 | 2023-02-06 | 9,738 | $33.36 | $324.9K | 245,374 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2023-02-03 | 2023-02-06 | 15,000 | $6.22 | $93.3K | 255,112 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-02-03 | 2023-02-06 | 5,262 | $34.08 | $179.3K | 240,112 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2023-02-02 | 2023-02-06 | 15,000 | — | $0 | 342,262 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2023-02-02 | 2023-02-06 | 15,000 | $6.22 | $93.3K | 255,112 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-02-02 | 2023-02-06 | 13,395 | $34.13 | $457.2K | 241,717 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-02-02 | 2023-02-06 | 1,605 | $34.96 | $56.1K | 240,112 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2023-02-01 | 2023-02-01 | 15,000 | — | $0 | 357,262 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-02-01 | 2023-02-01 | 105 | $35.55 | $3.7K | 240,112 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-02-01 | 2023-02-01 | 5,440 | $34.78 | $189.2K | 240,217 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-02-01 | 2023-02-01 | 9,455 | $34.15 | $322.9K | 245,657 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2023-02-01 | 2023-02-01 | 15,000 | $6.22 | $93.3K | 255,112 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2023-01-31 | 2023-02-01 | 10,539 | — | $0 | 146,841 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2023-01-31 | 2023-02-01 | 4,461 | — | $0 | 372,262 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2023-01-31 | 2023-02-01 | 4,461 | $6.22 | $27.7K | 255,112 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-01-31 | 2023-02-01 | 15,000 | $34.92 | $523.8K | 240,112 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2023-01-31 | 2023-02-01 | 10,539 | $2.08 | $21.9K | 250,651 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2023-01-30 | 2023-02-01 | 15,000 | — | $0 | 157,380 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2023-01-30 | 2023-02-01 | 15,000 | $2.08 | $31.2K | 255,112 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-01-30 | 2023-02-01 | 11,395 | $33.98 | $387.2K | 243,717 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-01-30 | 2023-02-01 | 3,605 | $34.66 | $124.9K | 240,112 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-01-27 | 2023-01-27 | 9,779 | $35.09 | $343.1K | 409,538 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-01-27 | 2023-01-27 | 221 | $36.64 | $8.1K | 409,317 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-01-27 | 2023-01-27 | 6,302 | $36.06 | $227.3K | 240,112 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-01-27 | 2023-01-27 | 8,698 | $35.42 | $308.1K | 246,414 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2023-01-27 | 2023-01-27 | 15,000 | $2.08 | $31.2K | 255,112 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2023-01-26 | 2023-01-27 | 15,000 | — | $0 | 187,380 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2023-01-26 | 2023-01-27 | 15,000 | — | $0 | 172,380 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-01-26 | 2023-01-27 | 15,000 | $35.10 | $526.5K | 419,317 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2023-01-26 | 2023-01-27 | 15,000 | $2.08 | $31.2K | 255,112 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-01-26 | 2023-01-27 | 15,000 | $35.29 | $529.4K | 240,112 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2023-01-25 | 2023-01-25 | 15,000 | — | $0 | 202,380 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2023-01-25 | 2023-01-27 | 206,300 | — | $0 | 206,300 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2023-01-25 | 2023-01-25 | 15,000 | $2.08 | $31.2K | 108,812 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-01-25 | 2023-01-25 | 1,696 | $33.29 | $56.5K | 93,812 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-01-25 | 2023-01-25 | 13,304 | $32.40 | $431.0K | 95,508 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2023-01-25 | 2023-01-27 | 146,300 | — | $0 | 240,112 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2023-01-24 | 2023-01-25 | 15,000 | — | $0 | 217,380 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-01-24 | 2023-01-25 | 15,000 | $30.89 | $463.4K | 93,812 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2023-01-24 | 2023-01-25 | 15,000 | $2.08 | $31.2K | 108,812 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2023-01-23 | 2023-01-25 | 15,000 | — | $0 | 232,380 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-01-23 | 2023-01-25 | 10,150 | $33.71 | $342.2K | 98,662 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2023-01-23 | 2023-01-25 | 15,000 | $2.08 | $31.2K | 108,812 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-01-23 | 2023-01-25 | 4,850 | $34.93 | $169.4K | 93,812 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-01-23 | 2023-01-25 | 15,000 | $35.00 | $525.0K | 434,317 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2023-01-09 | 2023-01-09 | 5,000 | — | $0 | 247,380 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-01-09 | 2023-01-09 | 5,000 | $19.17 | $95.9K | 93,812 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2023-01-09 | 2023-01-09 | 5,000 | $2.08 | $10.4K | 98,812 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2023-01-06 | 2023-01-09 | 15,000 | — | $0 | 252,380 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2023-01-06 | 2023-01-09 | 15,000 | $2.08 | $31.2K | 108,812 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-01-06 | 2023-01-09 | 15,000 | $19.04 | $285.6K | 93,812 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2023-01-04 | 2023-01-05 | 15,000 | — | $0 | 267,380 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2023-01-04 | 2023-01-05 | 15,000 | $2.08 | $31.2K | 108,812 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-01-04 | 2023-01-05 | 15,000 | $19.06 | $285.9K | 93,812 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2023-01-03 | 2023-01-05 | 15,000 | — | $0 | 282,380 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-01-03 | 2023-01-05 | 15,000 | $19.33 | $289.9K | 93,812 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2023-01-03 | 2023-01-05 | 15,000 | $2.08 | $31.2K | 108,812 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2022-12-20 | 2022-12-21 | 34,212 | $19.10 | $653.4K | 93,812 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2022-12-19 | 2022-12-21 | 68,751 | — | $0 | 128,024 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2022-09-12 | 2022-09-14 | 12,502 | — | $0 | 297,380 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2022-09-12 | 2022-09-14 | 12,502 | $2.08 | $26.0K | 71,775 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2022-09-12 | 2022-09-14 | 12,502 | $22.54 | $281.8K | 59,273 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2022-07-12 | 2022-07-13 | 12,498 | — | $0 | 309,882 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2022-07-12 | 2022-07-13 | 12,498 | $2.08 | $26.0K | 71,771 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2022-07-12 | 2022-07-13 | 12,498 | $22.50 | $281.2K | 59,273 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2022-07-11 | 2022-07-13 | 15,000 | — | $0 | 322,380 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2022-07-11 | 2022-07-13 | 15,000 | $22.50 | $337.5K | 59,273 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2022-07-11 | 2022-07-13 | 15,000 | $2.08 | $31.2K | 74,273 | SEC↗ |
| SQZ SQZ Biotechnologies Co | A Award deriv | 2022-06-15 | 2022-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2022-01-26 | 2022-02-02 | 440,000 | — | $0 | 440,000 | SEC↗ |
| SQZ SQZ Biotechnologies Co | A Award deriv | 2021-07-01 | 2021-07-01 | 21,000 | — | $0 | 21,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2021-06-14 | 2021-06-15 | 3,757 | $32.98 | $123.9K | 449,560 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2021-06-14 | 2021-06-15 | 243 | $33.69 | $8.2K | 449,317 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2021-05-14 | 2021-05-17 | 2,997 | $28.53 | $85.5K | 453,820 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2021-05-14 | 2021-05-17 | 503 | $29.28 | $14.7K | 453,317 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2021-04-14 | 2021-04-15 | 3,500 | $30.33 | $106.2K | 456,817 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2021-04-13 | 2021-04-15 | 6,000 | — | $0 | 337,380 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2021-04-13 | 2021-04-15 | 6,000 | $2.08 | $12.5K | 54,840 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2021-03-15 | 2021-03-17 | 178 | $39.69 | $7.1K | 460,317 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2021-03-15 | 2021-03-17 | 2,000 | $38.75 | $77.5K | 460,495 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2021-03-15 | 2021-03-17 | 1,322 | $38.03 | $50.3K | 462,495 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2021-02-16 | 2021-02-17 | 200 | $34.07 | $6.8K | 463,817 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2021-02-16 | 2021-02-17 | 1,200 | $32.10 | $38.5K | 466,117 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2021-02-16 | 2021-02-17 | 2,100 | $32.87 | $69.0K | 464,017 | SEC↗ |
| PLRX | A Award deriv | 2021-01-23 | 2021-01-26 | 250,000 | — | $0 | 250,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2021-01-14 | 2021-01-15 | 2,870 | $26.20 | $75.2K | 467,947 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2021-01-14 | 2021-01-15 | 630 | $27.21 | $17.1K | 467,317 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2020-12-14 | 2020-12-16 | 337 | $27.86 | $9.4K | 470,817 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2020-12-14 | 2020-12-16 | 3,163 | $27.32 | $86.4K | 471,154 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion deriv | 2020-06-05 | 2020-06-09 | 181,594 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion | 2020-06-05 | 2020-06-09 | 25,397 | — | $0 | 474,317 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2020-04-30 | 2020-06-09 | 48,227 | — | $0 | 343,380 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2020-04-30 | 2020-06-09 | 613 | — | $0 | 376,723 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2020-04-30 | 2020-06-09 | 613 | $6.22 | $3.8K | 613 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2020-04-30 | 2020-06-09 | 48,227 | $2.08 | $100.3K | 48,840 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2020-03-31 | 2020-06-09 | 377,336 | — | $0 | 377,336 | SEC↗ |